文献速递儿童青少年精神心境障碍焦虑、强迫与应激相关障碍

青少年抑郁焦虑中SSRI治疗已知与未知:疗效、预测因素与作用机制

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.
PubMed 文献 · Lancet Psychiatry · 2021-01-01

本文综述临床试验中SSRI在青少年抑郁和焦虑中的获益与风险证据,并结合人类实验和动物模型探讨其作用机制。文章强调需刻画该年龄组SSRI获益与风险的机制以推进领域发展,并缩小SSRI广泛使用与其科学基础之间的鸿沟。

要点

  • SSRI用于青少年抑郁和焦虑日益增多,但青少年期神经、认知和社会功能变化大,药物效应尚不充分理解。
  • 综述临床试验证据评估SSRI在青少年中的获益与风险,并通过人类实验和动物模型讨论作用机制。
  • 强调需明确该年龄组SSRI获益与风险的机制,以缩小广泛用药与科学基础之间的差距。

核心结论

  • 需刻画青少年SSRI获益与风险的机制以推进领域发展,并缩小SSRI广泛使用与其科学基础之间的鸿沟。

研究设计与样本

  • 综述临床试验中SSRI在青少年抑郁和焦虑中的获益与风险证据,并结合人类实验工作和动物模型探讨作用机制。

主要发现

  • SSRI在青少年抑郁和焦虑中的使用正在增加。
  • 青少年期神经、认知和社会功能发生显著变化,但SSRI在该时期的效果尚未被充分理解。
  • 通过文献空白和与有亲身经历的年轻人咨询,识别出关于SSRI在青少年中效应的关键未决问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The use of SSRIs for the treatment of depression and anxiety in young people is increasing. However, the effects of SSRIs in adolescence, a time when there are substantial changes in neural, cognitive, and social functioning, are not well understood. Here, we review evidence from clinical trials about the benefits and risks of SSRIs in young people and consider their mechanisms of action, as shown through human experimental work and animal models. We emphasise key outstanding questions about the effects of SSRIs in youth, identified through gaps in the literature and in consultation with young people with lived experience. It is crucial to characterise the mechanisms underpinning risks and benefits of SSRIs in this age group to progress the field, and to narrow the chasm between the widespread use of SSRIs in youth and the science on which this use is based.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Murphy SE, Capitão LP, Giles SLC, et al. The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action. Lancet Psychiatry. 2021. PMID: 34419187. doi:10.1016/S2215-0366(21)00154-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。